Clinical Trials List
2017-11-01 - 2027-12-31
Phase III
Terminated9
ICD-10C22
Malignant neoplasm of liver and intrahepatic bile ducts
ICD-10C22.0
Liver cell carcinoma
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Yi-Hsiang Huang Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- Rheun-Chuan Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
9 Completed
Audit
None
Co-Principal Investigator
- 劉奕廷 Division of Hematology & Oncology
- Yih-Jyh Lin Division of General Surgery
- Shang-Yin Wu Division of Hematology & Oncology
- Chiu Hung Chiu Digestive System Department
- 簡世杰 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- Chiun Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- Chien-Hung Chen Digestive System Department
- YU-YUN SHAO Division of Hematology & Oncology
- 林宗哲 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Li-Yuan Bai Division of Hematology & Oncology
- 許家豪 Division of General Surgery
- Hsueh-Chou Lai Digestive System Department
- Long-Bin Jeng Division of Others -
- Po-Heng Chuang 未分科
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 顏志雄 Digestive System Department
- 陳秉聰 Digestive System Department
- 盧勝男 Digestive System Department
- 許晃維 Digestive System Department
- 沈建亨 Digestive System Department
- 董水義 Digestive System Department
- 陳慰明 Digestive System Department
- 許勝榮 Digestive System Department
- 張德生 Digestive System Department
- 陳奕行 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- Tsai-Sheng Yang Division of Hematology & Oncology
- Cheng-Lung Hsu Division of Hematology & Oncology
- Chien-Hao Huang Digestive System Department
- 潘廣澤 Division of Radiology
- Ming-Mo Hou Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Chen-Chun Lin Digestive System Department
- 呂嘉偉 Division of Radiology
- Chia-Hsun Hsieh Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- Ming-Chin Yu Division of General Surgery
- Wen-Chi Chou Division of Hematology & Oncology
- Shi-Ming Lin Digestive System Department
- Kun-Ming Chan Division of General Surgery
The Actual Total Number of Participants Enrolled
6 Completed
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
120 participants
-
Global
1310 participants
